Intravenous Iron Drugs Market

Mar 2021| MRS118A| Market Research Studies

Report Highlights

The scope of this report covers the different types of Intravenous Iron Drugs, impact of COVID-19 on the market, and usage of drugs for the treatment of various chronic diseases. The report covers the market value for the historic year 2019, followed by the base year 2020, estimated year 2021 and forecast period from 2020 to 2026 for each product type, application, route of administration, end-user and regional markets, and the estimated values are derived from the manufacturers’ total revenues.

The report also includes a discussion of the major players across each of the regional Intravenous Iron Drugs markets; it explains the major market drivers of the Global Intravenous Iron Drugs industry, current trends within the industry, major applications, and the regional dynamics of the Global Intravenous Iron Drugs Market.

The report concludes with a special focus on the vendor landscape, which includes detailed profiles of the major vendors in the Global Intravenous Iron Drugs Market.

Report Includes

  • 42 tables and 50 figures
  • An up-to-date analysis of the Global Intravenous Iron Drugs Market.
  • Analyses of the global market trends, with data from 2019, 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026.
  • Estimation of market size and revenue forecast for Global Intravenous Iron Drugs Market, and corresponding market share analysis by product type, application, route of administration, end-user, and region.
  • Highlights of emerging technology trends, gaps and opportunities in the market estimating current and future demand for Intravenous Iron Drugs, identification of the companies that are best positioned to meet this demand.
  • In-depth information (facts and figures) concerning market drivers, restraints and other forces affecting the progress of this market.
  • Identification of promising new drugs, and products still in the development and testing stages, and their probability of successful commercial launch within the next five years
  • Impact of COVID-19 on the Intravenous Iron Drugs Market as compared to overall global economy.
  • Insight into the growth development strategies of major Intravenous Iron Drugs manufacturers and their key competitive landscape
  • Descriptive company profiles of the leading market participants, including Allergan, Inc., Shield Therapeutics Plc, Pharmacosmos A/S, Vifor Pharma AG, Fresenius Medical Care AG & Co. KGaA, Sanofi S.A., and others.

Summary

Iron is one of the essential minerals of the human body. Iron plays a key role in various biological processes such as, energy metabolism, oxygen transport and many others. The iron supplements are readily available in mainly two forms i.e., oral and intravenous. Intravenous iron supplements are more effective than the oral dosage as the former lead to faster increase of Hb and iron levels in the body. However, the intravenous treatment is quite expensive than the oral treatment. As per the American Society of Haematology, the most common blood disorder has been recorded as anaemia. While the National Heart, Lung, and Blood Institute states that anaemia affects more than 3 million population of America.

Increasing prevalence of diseases such chronic kidney disease, inflammatory bowel disease and many other are some of the leading factors influencing the growth of global intravenous iron drugs market. Apart from this, rising geriatric population and increasing iron deficiency among the population are also going to propel the market. However, stringent regulations are posing a threat for the drugs approvals which further creates hindrance in the overall market growth.

The Global Intravenous Iron Drugs Market was valued at $1.75 billion in 2020 and is expected to witness a steady growth at a CAGR of 6.84%.

  • Table 1 : Global Intravenous Iron Drugs Market, Through 2026
  • Table 2 : Global Intravenous Iron Drugs Market, by Product Type, Through 2026
  • Table 3 : Global Intravenous Iron Drugs Market, by Application, Through 2026
  • Table 4 : Global Intravenous Iron Drugs Market, by Route of Administration, Through 2026
  • Table 5 : Global Intravenous Iron Drugs Market, by End-User, Through 2026
  • Table 6 : Global Intravenous Iron Drugs Market, by Region, Through 2026
  • Table 7 : North America Intravenous Iron Drugs Market, by Product Type, Through 2026
  • Table 8 : North America Intravenous Iron Drugs Market, by Application, Through 2026
  • Table 9 : North America Intravenous Iron Drugs Market, by Route of Administration, Through 2026
  • Table 10 : North America Intravenous Iron Drugs Market, by End-User, Through 2026
  • Table 11 : North America Intravenous Iron Drugs Market, by Country, Through 2026
  • Table 12 : Europe Intravenous Iron Drugs Market, by Product Type, Through 2026
  • Table 13 : Europe Intravenous Iron Drugs Market, by Application, Through 2026
  • Table 14 : Europe Intravenous Iron Drugs Market, by Route of Administration, Through 2026
  • Table 15 : Europe Intravenous Iron Drugs Market, by End-User, Through 2026
  • Table 16 : Europe Intravenous Iron Drugs Market, by Country, Through 2026
  • Table 17 : Asia-Pacific Intravenous Iron Drugs Market, by Product Type, Through 2026
  • Table 18 : Asia-Pacific Intravenous Iron Drugs Market, by Application, Through 2026
  • Table 19 : Asia-Pacific Intravenous Iron Drugs Market, by Route of Administration, Through 2026
  • Table 20 : Asia-Pacific Intravenous Iron Drugs Market, by End-User, Through 2026
  • Table 21 : Asia-Pacific Intravenous Iron Drugs Market, by Country, Through 2026
  • Table 22 : South America Intravenous Iron Drugs Market, by Product Type, Through 2026
  • Table 23 : South America Intravenous Iron Drugs Market, by Application, Through 2026
  • Table 24 : South America Intravenous Iron Drugs Market, by Route of Administration, Through 2026
  • Table 25 : South America Intravenous Iron Drugs Market, by End-User, Through 2026
  • Table 26 : South America Intravenous Iron Drugs Market, by Country, Through 2026
  • Table 27 : Middle East & Africa Intravenous Iron Drugs Market, by Product Type, Through 2026
  • Table 28 : Middle East & Africa Intravenous Iron Drugs Market, by Application, Through 2026
  • Table 29 : Middle East & Africa Intravenous Iron Drugs Market, by Route of Administration, Through 2026
  • Table 30 : Middle East & Africa Intravenous Iron Drugs Market, by End-User, Through 2026
  • Table 31 : Middle East & Africa Intravenous Iron Drugs Market, by Country, Through 2026
  • Table 32 : Allergan, Inc.: Financial Performance, Through 2020
  • Table 33 : Shield Therapeutics Plc: Financial Performance, Through 2020
  • Table 34 : Pharmacosmos A/S: Financial Performance, Through 2020
  • Table 35 : Vifor Pharma AG: Financial Performance, Through 2020
  • Table 36 : Fresenius Medical Care AG & Co. KGaA: Financial Performance, Through 2020
  • Table 37 : Sanofi S.A.: Financial Performance, Through 2020
  • Table 38 : AMAG Pharmaceuticals. Inc.: Financial Performance, Through 2020
  • Table 39 : Rockwell Medical Inc.: Financial Performance, Through 2020
  • Table 40 : Daiichi Sankyo Company, Limited: Financial Performance, Through 2020
  • Table 41 : The Takeda Pharmaceutical Company Limited: Financial Performance, Through 2020
  • Table 42 : Akebia Therapeutics, Inc.: Financial Performance, Through 2020
  • Figure 1 : Global Intravenous Iron Drugs Market
  • Figure 2 : Global Intravenous Iron Drugs Market, by Value, 2019-2026
  • Figure 3 : Global Intravenous Iron Drugs Market, by Value, by Product Type, 2019-2026
  • Figure 4 : Global Intravenous Iron Drugs Market, by Value, by Application, 2019-2026
  • Figure 5 : Global Intravenous Iron Drugs Market, by Value, by Route of Administration, 2019-2026
  • Figure 6 : Global Intravenous Iron Drugs Market, by Value, by End-User, 2019-2026
  • Figure 7 : Global Intravenous Iron Drugs Market, by Value, by Region, 2020
  • Figure 8 : Global Intravenous Iron Drugs Market, by Value, by Company, 2020
  • Figure 9 : Global Intravenous Iron Drugs Market, Product Map, 2020
  • Figure 10 : North America Intravenous Iron Drugs Market, by Value, 2019-2026
  • Figure 11 : North America Intravenous Iron Drugs Market, by Value, by Product Type, 2019-2026
  • Figure 12 : North America Intravenous Iron Drugs Market, by Value, by Application, 2019-2026
  • Figure 13 : North America Intravenous Iron Drugs Market, by Value, by Route of Administration, 2019-2026
  • Figure 14 : North America Intravenous Iron Drugs Market, by Value, by End-User, 2019-2026
  • Figure 15 : North America Intravenous Iron Drugs Market, by Value, by Country, 2020
  • Figure 16 : Europe Intravenous Iron Drugs Market, by Value, 2019-2026
  • Figure 17 : Europe Intravenous Iron Drugs Market, by Value, by Product Type, 2019-2026
  • Figure 18 : Europe Intravenous Iron Drugs Market, by Value, by Application, 2019-2026
  • Figure 19 : Europe Intravenous Iron Drugs Market, by Value, by Route of Administration, 2019-2026
  • Figure 20 : Europe Intravenous Iron Drugs Market, by Value, by End-User, 2019-2026
  • Figure 21 : Europe Intravenous Iron Drugs Market, by Value, by Country, 2020
  • Figure 22 : Asia-Pacific Intravenous Iron Drugs Market, by Value, 2019-2026
  • Figure 23 : Asia-Pacific Intravenous Iron Drugs Market, by Value, by Product Type, 2019-2026
  • Figure 24 : Asia-Pacific Intravenous Iron Drugs Market, by Value, by Application, 2019-2026
  • Figure 25 : Asia-Pacific Intravenous Iron Drugs Market, by Value, by Route of Administration, 2019-2026
  • Figure 26 : Asia-Pacific Intravenous Iron Drugs Market, by Value, by End-User, 2019-2026
  • Figure 27 : Asia-Pacific Intravenous Iron Drugs Market, by Value, by Country, 2020
  • Figure 28 : South America Intravenous Iron Drugs Market, by Value, 2019-2026
  • Figure 29 : South America Intravenous Iron Drugs Market, by Value, by Product Type, 2019-2026
  • Figure 30 : South America Intravenous Iron Drugs Market, by Value, by Application, 2019-2026
  • Figure 31 : South America Intravenous Iron Drugs Market, by Value, by Route of Administration, 2019-2026
  • Figure 32 : South America Intravenous Iron Drugs Market, by Value, by End-User, 2019-2026
  • Figure 33 : South America Intravenous Iron Drugs Market, by Value, by Country, 2020
  • Figure 34 : Middle East & Africa Intravenous Iron Drugs Market, by Value, 2019-2026
  • Figure 35 : Middle East & Africa Intravenous Iron Drugs Market, by Value, by Product Type, 2019-2026
  • Figure 36 : Middle East & Africa Intravenous Iron Drugs Market, by Value, by Application, 2019-2026
  • Figure 37 : Middle East & Africa Intravenous Iron Drugs Market, by Value, by Route of Administration, 2019-2026
  • Figure 38 : Middle East & Africa Intravenous Iron Drugs Market, by Value, by End-User, 2019-2026
  • Figure 39 : Middle East & Africa Intravenous Iron Drugs Market, by Value, by Country, 2020
  • Figure 40 : Allergan, Inc.: Revenue Share, 2020
  • Figure 41 : Shield Therapeutics Plc: Revenue Share, 2020
  • Figure 42 : Pharmacosmos A/S: Revenue Share, 2020
  • Figure 43 : Vifor Pharma AG: Revenue Share, 2020
  • Figure 44 : Fresenius Medical Care AG & Co. KGaA: Revenue Share, 2020
  • Figure 45 : Sanofi S.A.: Revenue Share, 2020
  • Figure 46 : AMAG Pharmaceuticals. Inc.: Revenue Share, 2020
  • Figure 47 : Rockwell Medical Inc.: Revenue Share, 2020
  • Figure 48 : Daiichi Sankyo Company, Limited: Revenue Share, 2020
  • Figure 49 : The Takeda Pharmaceutical Company Limited: Revenue Share, 2020
  • Figure 50 : Akebia Therapeutics, Inc.: Revenue Share, 2020

Market Research Studies is a North Carolina based, premier market research company. MRS brings over 50 years of market research publishing experience. Our reports cover a variety of industries such as Healthcare, Chemicals, Materials & Manufacturing, Research & Diagnostics, Environment & Sustainability, among others. Each year MRS releases hundreds of reports covering various topics. These reports are prepared by our in-house of team of Industry expert analysts. We strive to provide in-depth market analysis with accurate data to help our customers make informed decisions.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report